-

Hims & Hers Appoints Senior Vice President of Mental Health Advancing Efforts to Provide the Highest Quality of Innovative Care for Anxiety and Depression

Dr. Daniel Lieberman was previously a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform on a mission to help the world feel great through the power of better health, today announces a key leadership appointment, naming psychiatry and behavioral sciences industry veteran Dr. Daniel Lieberman, M.D., as the company’s Senior Vice President of Mental Health.

In this role, Dr. Lieberman will oversee the psychiatry and mental wellness strategy at Hims & Hers, working to ensure this category continues to deliver clinical excellence, a trusted customer experience, leading technology as well as innovative products and services. Dr. Lieberman will focus on further developing and expanding the availability of personalized health and wellness treatments surrounding anxiety and depression.

“In order to break down the stigma associated with mental health, we are taking a customer-centric approach that removes barriers, accelerates access, and delivers clinical excellence at its core, which is fundamental at Hims & Hers,” said Andrew Dudum, Co-Founder and Chief Executive Officer at Hims & Hers. “As Senior Vice President of Mental Health, Dr. Lieberman will leverage his proven leadership, expertise and prominence in the field to further enhance our services, and play an integral role in our efforts to modernize mental healthcare.”

Hims & Hers provides access to a variety of mental health services, including for customers who may be experiencing symptoms of anxiety or depression, which can include psychiatry services and subscription medication, therapy sessions, and free virtual support group sessions.

“I’m extraordinarily passionate about increasing access to high-quality mental healthcare as the fact is, millions of Americans today still struggle to find treatments and resources that work for them,” said Dr. Daniel Lieberman. “What piqued my interest in working with Hims & Hers is how the company is looking to revolutionize mental health services with treatments that are accessible yet tailored to individual needs, considering both their symptoms as well as preferences. In peeling back the layers of the company’s mental health platform, I was sincerely impressed to see they employ extremely high standards of care and work tirelessly to provide a welcoming, comforting, safe and effective experience for customers. It’s a privilege to play a role in making Hims & Hers’ vision for healthcare come to life.”

Dr. Lieberman brings more than two decades of leadership and industry expertise to the role. Prior to joining Hims & Hers, he served as a Clinical Professor of Psychiatry and Behavioral Sciences at George Washington University. He is a Distinguished Fellow of the American Psychiatric Association, a recipient of the Caron Foundation Research Award, and has published over 50 scientific reports on behavioral science.

He has been a trusted advisor on psychiatric topics for the U.S. Department of Health & Human Services, the U.S. Department of Commerce, and the Office of Drug & Alcohol Policy & Compliance. Dr. Lieberman studied the Great Books at St. John's College, and received his medical degree and completed his psychiatric training at New York University.

Dr. Lieberman is a renowned author with international bestseller The Molecule of More, which has been translated into more than 20 languages, and Spellbound: Modern Science, Ancient Magic, and the Unconscious Mind, an exploration of the intersection of neuroscience and mysticism as it relates to our experience of our unconscious.

​​Today’s announcement comes on the heels of a record quarterly earnings report. In Q4 2022, the company surpassed one million subscribers and reported record revenue of $526.9 million, up 94% year-over-year. To see the full Q4 2022 results, click here.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit https://investors.forhims.com/.

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

More News From Hims & Hers Health, Inc.

Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health,...

Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advance...

Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) has completed its acquisition of Eucalyptus, advancing its position as the world's largest consumer health platform. Building on the earlier acquisitions of ZAVA and Livewell, Hims & Hers now has a leading presence across the US, UK, Australian, and Canadian markets, with a growing presence in France, Germany, Ireland, Spain, and Japan. Continuing to expand internationally will enable Hims & Hers to lead the next...
Back to Newsroom